As NLRP3 is a key immune regulator, inhibitors of NLRP3 such as MCC950, cy-09, and OLT1177 are proven to have neuroprotective effects [213] and alleviate cognitive impairment, and also support cognitive development in AD [214]. Here, NLRP3 is linked to Alzheimer disease.